BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31219767)

  • 1. Serum IL-6 and sIL-6R in type 2 diabetes contribute to impaired capillary-like network formation.
    Landers-Ramos RQ; Blumenthal JB; Prior SJ
    J Appl Physiol (1985); 2019 Aug; 127(2):385-392. PubMed ID: 31219767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise-induced endothelial progenitor cell mobilization is attenuated in impaired glucose tolerance and type 2 diabetes.
    Lutz AH; Blumenthal JB; Landers-Ramos RQ; Prior SJ
    J Appl Physiol (1985); 2016 Jul; 121(1):36-41. PubMed ID: 27197857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low clonogenic potential of circulating angiogenic cells is associated with lower density of capillaries in skeletal muscle in patients with impaired glucose tolerance.
    Prior SJ; Ryan AS
    Diabetes Metab Res Rev; 2013 May; 29(4):319-25. PubMed ID: 23390082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.
    Shalitin S; Deutsch V; Tauman R
    J Endocrinol Invest; 2018 Aug; 41(8):969-975. PubMed ID: 29305826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women.
    Rashad NM; El-Shal AS; Etewa RL; Wadea FM
    IUBMB Life; 2017 Feb; 69(2):88-97. PubMed ID: 28116808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
    Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
    Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes.
    Baldane S; Ipekci SH; Ekin A; Abusoglu S; Unlu A; Kebapcilar L
    Bratisl Lek Listy; 2018; 119(2):112-115. PubMed ID: 29455547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
    Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
    Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.
    Ohashi K; Komada H; Uda S; Kubota H; Iwaki T; Fukuzawa H; Komori Y; Fujii M; Toyoshima Y; Sakaguchi K; Ogawa W; Kuroda S
    PLoS One; 2015; 10(12):e0143880. PubMed ID: 26623647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
    Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss.
    Corpeleijn E; Saris WH; Jansen EH; Roekaerts PM; Feskens EJ; Blaak EE
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5819-24. PubMed ID: 16030153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.